Login/Sign Up
₹11500.02
(Inclusive of all Taxes)
₹1725.0 Cashback (15%)
Encrpc-160 mg Tablet 7's is used to treat prostate cancer. It contains Enzalutamide, an androgen receptor blocker (inhibitor) that blocks testosterone from reaching prostate cancer cells. Most prostate cancers require testosterone to grow; this can slow the growth of the cancer and may shrink it. Enzalutamide is only for use in men. Men using this medication must use effective birth control whenever they have sex during their treatment and for three months after their final dose.
Provide Delivery Location
Whats That
About Encrpc-160 mg Tablet 7's
Encrpc-160 mg Tablet 7's belongs to a group of medicines known as androgen receptor inhibitors. It is used to treat prostate cancer. Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can attack and destroy surrounding healthy tissue, including organs. Prostate cancer is a type of cancer that only occurs in men and affects the prostate gland, a tiny gland under the bladder that produces semen.
Encrpc-160 mg Tablet 7's contains Enzalutamide, an androgen receptor blocker (inhibitor). Enzalutamide blocks testosterone from reaching prostate cancer cells. Most prostate cancers require testosterone to grow. This can slow the growth of the cancer and may shrink it.
Use this medicine as directed by your doctor. You may sometimes experience trouble breathing (pneumonia), weakness or feeling more tired than usual, back pain, diarrhoea, pain in your joints, swelling (in your hands, arms, legs or feet), muscle or bone pain, muscle weakness, headache, cold-like symptoms, dizziness, high blood pressure and trouble falling or staying asleep (insomnia). Most of these side effects may gradually resolve over time. However, if the side effects persist or worsen, consult your doctor.
Enzalutamide is only for use in men. Men using this Encrpc-160 mg Tablet 7's must use effective birth control whenever they have sex during your treatment and for three months after their final dose. In rare cases, Encrpc-160 mg Tablet 7's may cause seizures, so tell your doctor if you have or have ever had seizures. Because of the risk of seizure associated with Encrpc-160 mg Tablet 7's use, patients should be advised of the risk of engaging in any activity where sudden loss of consciousness could cause serious harm to themselves or others. Consumption of alcohol is strictly avoided.
Uses of Encrpc-160 mg Tablet 7's
Encrpc-160 mg Tablet 7's is used in the treatment of Prostate Cancer. The detailed uses of Encrpc-160 mg Tablet 7's are as follows:<br/> • Metastatic castration-resistant prostate cancer (mCRPC): Encrpc-160 mg Tablet 7's is used to treat prostate cancer that continues to progress despite low testosterone levels. It is typically prescribed when the cancer has spread to other parts of the body and no longer responds to hormone therapy.<br/> • Non-metastatic castration-resistant prostate cancer (nmCRPC): Encrpc-160 mg Tablet 7's is used in patients whose prostate cancer has not yet spread but is no longer responding to medical or surgical treatments that lower testosterone.<br/> • Hormone-sensitive metastatic prostate cancer: Encrpc-160 mg Tablet 7's is used in combination with androgen deprivation therapy (ADT) to treat prostate cancer that has spread but still responds to hormone-lowering treatments.<br/>
Directions for Use
Medicinal Benefits
Encrpc-160 mg Tablet 7's contains Enzalutamide, which belongs to a group of medicines known as androgen receptor inhibitors. Most prostate cancers require testosterone to grow. In men, the testicles produce the majority of testosterone. Adrenal glands (Just above each kidney) produce a small quantity of testosterone. Enzalutamide is preventing testosterone from reaching cancer cells in the prostate. This can inhibit the growth of the cancer and even cause it to shrink.
How Encrpc-160 mg Tablet 7's Works
Storage
What if I have taken an overdose of Encrpc-160 mg Tablet 7's
Drug Warnings
Do not take Encrpc-160 mg Tablet 7's if you are allergic or hypersensitive to any component present in it. You must take Enzalutamide according to the instructions your doctor or pharmacist gives you. You must take Enzalutamide exactly as prescribed by your doctor or pharmacist. You must take the correct dose, not more or less. Consult your healthcare team before discontinuing Encrpc-160 mg Tablet 7's or missing a dose. Talk to your doctor before taking Encrpc-160 mg Tablet 7's if you have severe allergic reactions to medicines or foods or suffer from any medical illness. Use a condom or effective birth control method if you are having sex with pregnant women or women who can become pregnant.
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Product Substitutes
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with Encrpc-160 mg Tablet 7's.
Pregnancy
Not applicable
Enzalutamide is only for use in men. Women should not take this medication.
Breast Feeding
Not applicable
Enzalutamide is only for use in men. Women should not take this medication.
Driving
Unsafe
Encrpc-160 mg Tablet 7's may affect your reactions and your ability to drive. Do not drive and/or operate machines that require your alertness.
Liver
Caution
In patients with mild or moderate liver impairment, there is no need to alter the initial dose. There is no information available on patients with severe liver impairment.
Kidney
Caution
In patients with mild or moderate kidney impairment, there is no need to alter the initial dose. There is no information available on patients with severe kidney impairment.
Children
Unsafe
The safety and effectiveness of Encrpc-160 mg Tablet 7's in pediatric patients have not been established.
Have a query?
Encrpc-160 mg Tablet 7's is used to treat prostate cancer in men.
Most prostate cancers require testosterone to grow. Encrpc-160 mg Tablet 7's contains Enzalutamide, which blocks testosterone, a hormone, from reaching prostate cancer cells. Thus, Encrpc-160 mg Tablet 7's can slow the cancer's growth and cause it to shrink.
Encrpc-160 mg Tablet 7's is only for use in men. Women should not take this medication, especially if they are or may become pregnant or are breast-feeding.
In some cases, Encrpc-160 mg Tablet 7's may cause decreased fertility in men. However, you should not assume that your female partner cannot become pregnant. Please discuss with your doctor if you have any concerns.
Enzalutamide, a prostate cancer medication, is used to treat prostate cancer.
Seizures may occur in patients receiving Encrpc-160 mg Tablet 7's. So, patients who have had a seizure, please inform your doctor about your condition. Your doctor may monitor your condition closely.
Yes, Enzalutamide was generally a well-tolerated medication. Take Encrpc-160 mg Tablet 7's pills exactly as directed by your healthcare provider. Do not change your dose or stop taking Encrpc-160 mg Tablet 7's unless your healthcare physician instructs you. If you encounter side symptoms, your healthcare provider may temporarily discontinue your Encrpc-160 mg Tablet 7's therapy or adjust your Encrpc-160 mg Tablet 7's dose.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information